nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—ABCB1—melanoma	0.254	1	CbGaD
Mefloquine—CYP3A4—Temozolomide—melanoma	0.0663	0.284	CbGbCtD
Mefloquine—CYP2D6—Vemurafenib—melanoma	0.0571	0.245	CbGbCtD
Mefloquine—ABCB1—Dactinomycin—melanoma	0.0403	0.173	CbGbCtD
Mefloquine—CYP3A4—Vemurafenib—melanoma	0.0363	0.156	CbGbCtD
Mefloquine—HBA2—dermis—melanoma	0.0293	0.163	CbGeAlD
Mefloquine—ABCB1—Docetaxel—melanoma	0.0208	0.0892	CbGbCtD
Mefloquine—HBA2—leg—melanoma	0.0193	0.108	CbGeAlD
Mefloquine—HBA1—hindlimb—melanoma	0.0188	0.105	CbGeAlD
Mefloquine—HBA2—hindlimb—melanoma	0.0172	0.0963	CbGeAlD
Mefloquine—HBA1—appendage—melanoma	0.0161	0.0899	CbGeAlD
Mefloquine—HBA2—appendage—melanoma	0.0148	0.0826	CbGeAlD
Mefloquine—CYP3A4—Docetaxel—melanoma	0.0125	0.0534	CbGbCtD
Mefloquine—HBA2—endothelium—melanoma	0.00893	0.0499	CbGeAlD
Mefloquine—HBA2—blood vessel—melanoma	0.00823	0.046	CbGeAlD
Mefloquine—HBA2—neck—melanoma	0.00589	0.0329	CbGeAlD
Mefloquine—HBA1—eye—melanoma	0.00477	0.0266	CbGeAlD
Mefloquine—HBA2—eye—melanoma	0.00438	0.0245	CbGeAlD
Mefloquine—HBA2—retina—melanoma	0.00434	0.0242	CbGeAlD
Mefloquine—HBA1—skin of body—melanoma	0.00415	0.0232	CbGeAlD
Mefloquine—HBA2—skin of body—melanoma	0.00381	0.0213	CbGeAlD
Mefloquine—HBA1—head—melanoma	0.00271	0.0151	CbGeAlD
Mefloquine—HBA2—head—melanoma	0.00249	0.0139	CbGeAlD
Mefloquine—HBA1—lymph node—melanoma	0.0019	0.0106	CbGeAlD
Mefloquine—HBA2—lymph node—melanoma	0.00174	0.00972	CbGeAlD
Mefloquine—ADORA2A—head—melanoma	0.00129	0.00723	CbGeAlD
Mefloquine—ADORA1—head—melanoma	0.00112	0.00624	CbGeAlD
Mefloquine—ABCB1—blood vessel—melanoma	0.000861	0.00481	CbGeAlD
Mefloquine—BCHE—skin of body—melanoma	0.000837	0.00467	CbGeAlD
Mefloquine—ADORA1—lymph node—melanoma	0.000783	0.00437	CbGeAlD
Mefloquine—ACHE—lymph node—melanoma	0.000778	0.00434	CbGeAlD
Mefloquine—BCHE—mammalian vulva—melanoma	0.000763	0.00426	CbGeAlD
Mefloquine—CYP19A1—head—melanoma	0.000758	0.00423	CbGeAlD
Mefloquine—Pneumonia—Dactinomycin—melanoma	0.000712	0.00441	CcSEcCtD
Mefloquine—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000702	0.00434	CcSEcCtD
Mefloquine—Decreased appetite—Vemurafenib—melanoma	0.000695	0.0043	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Vemurafenib—melanoma	0.00069	0.00427	CcSEcCtD
Mefloquine—Fatigue—Vemurafenib—melanoma	0.000689	0.00426	CcSEcCtD
Mefloquine—Pneumonia—Carmustine—melanoma	0.000666	0.00412	CcSEcCtD
Mefloquine—Agranulocytosis—Dactinomycin—melanoma	0.000661	0.00409	CcSEcCtD
Mefloquine—Renal failure—Carmustine—melanoma	0.000651	0.00403	CcSEcCtD
Mefloquine—Neuropathy peripheral—Carmustine—melanoma	0.00065	0.00402	CcSEcCtD
Mefloquine—Pneumonia—Temozolomide—melanoma	0.000644	0.00398	CcSEcCtD
Mefloquine—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000635	0.00393	CcSEcCtD
Mefloquine—Flushing—Bleomycin—melanoma	0.000632	0.00391	CcSEcCtD
Mefloquine—Body temperature increased—Vemurafenib—melanoma	0.000632	0.00391	CcSEcCtD
Mefloquine—Neuropathy peripheral—Temozolomide—melanoma	0.000628	0.00388	CcSEcCtD
Mefloquine—Deafness—Docetaxel—melanoma	0.000618	0.00382	CcSEcCtD
Mefloquine—Hepatic failure—Docetaxel—melanoma	0.000615	0.0038	CcSEcCtD
Mefloquine—Chills—Bleomycin—melanoma	0.000611	0.00378	CcSEcCtD
Mefloquine—Hepatobiliary disease—Temozolomide—melanoma	0.000606	0.00375	CcSEcCtD
Mefloquine—Alopecia—Bleomycin—melanoma	0.000602	0.00373	CcSEcCtD
Mefloquine—Erythema multiforme—Dactinomycin—melanoma	0.000601	0.00372	CcSEcCtD
Mefloquine—Erythema—Bleomycin—melanoma	0.000593	0.00367	CcSEcCtD
Mefloquine—Hallucination—Carmustine—melanoma	0.000592	0.00366	CcSEcCtD
Mefloquine—Flushing—Dactinomycin—melanoma	0.00059	0.00365	CcSEcCtD
Mefloquine—Hypersensitivity—Vemurafenib—melanoma	0.000589	0.00364	CcSEcCtD
Mefloquine—Connective tissue disorder—Carmustine—melanoma	0.000585	0.00362	CcSEcCtD
Mefloquine—Visual disturbance—Docetaxel—melanoma	0.000583	0.00361	CcSEcCtD
Mefloquine—Dermatitis bullous—Docetaxel—melanoma	0.000578	0.00358	CcSEcCtD
Mefloquine—Asthenia—Vemurafenib—melanoma	0.000573	0.00355	CcSEcCtD
Mefloquine—Visual impairment—Carmustine—melanoma	0.000573	0.00355	CcSEcCtD
Mefloquine—Hallucination—Temozolomide—melanoma	0.000572	0.00354	CcSEcCtD
Mefloquine—Chills—Dactinomycin—melanoma	0.00057	0.00353	CcSEcCtD
Mefloquine—Pruritus—Vemurafenib—melanoma	0.000565	0.0035	CcSEcCtD
Mefloquine—Connective tissue disorder—Temozolomide—melanoma	0.000565	0.00349	CcSEcCtD
Mefloquine—Alopecia—Dactinomycin—melanoma	0.000562	0.00347	CcSEcCtD
Mefloquine—Eye disorder—Carmustine—melanoma	0.000556	0.00344	CcSEcCtD
Mefloquine—Visual impairment—Temozolomide—melanoma	0.000554	0.00343	CcSEcCtD
Mefloquine—Erythema—Dactinomycin—melanoma	0.000553	0.00342	CcSEcCtD
Mefloquine—Flushing—Carmustine—melanoma	0.000552	0.00342	CcSEcCtD
Mefloquine—Ill-defined disorder—Bleomycin—melanoma	0.00055	0.00341	CcSEcCtD
Mefloquine—Diarrhoea—Vemurafenib—melanoma	0.000547	0.00338	CcSEcCtD
Mefloquine—BCHE—head—melanoma	0.000546	0.00305	CbGeAlD
Mefloquine—Erythema multiforme—Temozolomide—melanoma	0.000544	0.00336	CcSEcCtD
Mefloquine—Eye disorder—Temozolomide—melanoma	0.000537	0.00332	CcSEcCtD
Mefloquine—Tinnitus—Temozolomide—melanoma	0.000536	0.00332	CcSEcCtD
Mefloquine—Malaise—Bleomycin—melanoma	0.000535	0.00331	CcSEcCtD
Mefloquine—Flushing—Temozolomide—melanoma	0.000534	0.0033	CcSEcCtD
Mefloquine—Cardiac disorder—Temozolomide—melanoma	0.000534	0.0033	CcSEcCtD
Mefloquine—Leukopenia—Bleomycin—melanoma	0.000531	0.00329	CcSEcCtD
Mefloquine—CYP19A1—lymph node—melanoma	0.000531	0.00296	CbGeAlD
Mefloquine—Dizziness—Vemurafenib—melanoma	0.000528	0.00327	CcSEcCtD
Mefloquine—Alopecia—Carmustine—melanoma	0.000526	0.00325	CcSEcCtD
Mefloquine—Angiopathy—Temozolomide—melanoma	0.000522	0.00323	CcSEcCtD
Mefloquine—Mental disorder—Carmustine—melanoma	0.000521	0.00322	CcSEcCtD
Mefloquine—Ataxia—Docetaxel—melanoma	0.00052	0.00321	CcSEcCtD
Mefloquine—Mediastinal disorder—Temozolomide—melanoma	0.000518	0.00321	CcSEcCtD
Mefloquine—Malnutrition—Carmustine—melanoma	0.000518	0.0032	CcSEcCtD
Mefloquine—Erythema—Carmustine—melanoma	0.000518	0.0032	CcSEcCtD
Mefloquine—Chills—Temozolomide—melanoma	0.000516	0.00319	CcSEcCtD
Mefloquine—Ill-defined disorder—Dactinomycin—melanoma	0.000513	0.00318	CcSEcCtD
Mefloquine—Vomiting—Vemurafenib—melanoma	0.000508	0.00314	CcSEcCtD
Mefloquine—Alopecia—Temozolomide—melanoma	0.000508	0.00314	CcSEcCtD
Mefloquine—Chest pain—Bleomycin—melanoma	0.000505	0.00312	CcSEcCtD
Mefloquine—Myalgia—Bleomycin—melanoma	0.000505	0.00312	CcSEcCtD
Mefloquine—Rash—Vemurafenib—melanoma	0.000504	0.00312	CcSEcCtD
Mefloquine—Mental disorder—Temozolomide—melanoma	0.000504	0.00312	CcSEcCtD
Mefloquine—Dermatitis—Vemurafenib—melanoma	0.000503	0.00311	CcSEcCtD
Mefloquine—Headache—Vemurafenib—melanoma	0.000501	0.0031	CcSEcCtD
Mefloquine—Erythema—Temozolomide—melanoma	0.0005	0.0031	CcSEcCtD
Mefloquine—Malnutrition—Temozolomide—melanoma	0.0005	0.0031	CcSEcCtD
Mefloquine—Discomfort—Bleomycin—melanoma	0.000499	0.00309	CcSEcCtD
Mefloquine—Malaise—Dactinomycin—melanoma	0.000499	0.00309	CcSEcCtD
Mefloquine—Cramp muscle—Docetaxel—melanoma	0.000498	0.00308	CcSEcCtD
Mefloquine—Leukopenia—Dactinomycin—melanoma	0.000495	0.00306	CcSEcCtD
Mefloquine—Confusional state—Bleomycin—melanoma	0.000488	0.00302	CcSEcCtD
Mefloquine—Vision blurred—Carmustine—melanoma	0.000488	0.00302	CcSEcCtD
Mefloquine—Tremor—Carmustine—melanoma	0.000485	0.003	CcSEcCtD
Mefloquine—Oedema—Bleomycin—melanoma	0.000484	0.003	CcSEcCtD
Mefloquine—Anaphylactic shock—Bleomycin—melanoma	0.000484	0.003	CcSEcCtD
Mefloquine—Agitation—Carmustine—melanoma	0.000476	0.00294	CcSEcCtD
Mefloquine—Nausea—Vemurafenib—melanoma	0.000475	0.00294	CcSEcCtD
Mefloquine—Thrombocytopenia—Bleomycin—melanoma	0.000474	0.00293	CcSEcCtD
Mefloquine—Vision blurred—Temozolomide—melanoma	0.000472	0.00292	CcSEcCtD
Mefloquine—Myalgia—Dactinomycin—melanoma	0.000471	0.00291	CcSEcCtD
Mefloquine—Tremor—Temozolomide—melanoma	0.000469	0.0029	CcSEcCtD
Mefloquine—Discomfort—Dactinomycin—melanoma	0.000465	0.00288	CcSEcCtD
Mefloquine—Ill-defined disorder—Temozolomide—melanoma	0.000464	0.00287	CcSEcCtD
Mefloquine—Leukopenia—Carmustine—melanoma	0.000464	0.00287	CcSEcCtD
Mefloquine—Agitation—Temozolomide—melanoma	0.00046	0.00285	CcSEcCtD
Mefloquine—ABCB1—retina—melanoma	0.000454	0.00254	CbGeAlD
Mefloquine—Hypotension—Bleomycin—melanoma	0.000452	0.0028	CcSEcCtD
Mefloquine—Oedema—Dactinomycin—melanoma	0.000452	0.00279	CcSEcCtD
Mefloquine—Malaise—Temozolomide—melanoma	0.000451	0.00279	CcSEcCtD
Mefloquine—Vertigo—Temozolomide—melanoma	0.00045	0.00278	CcSEcCtD
Mefloquine—Convulsion—Carmustine—melanoma	0.000449	0.00278	CcSEcCtD
Mefloquine—Leukopenia—Temozolomide—melanoma	0.000448	0.00277	CcSEcCtD
Mefloquine—Hypertension—Carmustine—melanoma	0.000447	0.00277	CcSEcCtD
Mefloquine—Palpitations—Temozolomide—melanoma	0.000442	0.00274	CcSEcCtD
Mefloquine—Thrombocytopenia—Dactinomycin—melanoma	0.000442	0.00274	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000441	0.00273	CcSEcCtD
Mefloquine—Chest pain—Carmustine—melanoma	0.000441	0.00273	CcSEcCtD
Mefloquine—Myalgia—Carmustine—melanoma	0.000441	0.00273	CcSEcCtD
Mefloquine—Anxiety—Carmustine—melanoma	0.000439	0.00272	CcSEcCtD
Mefloquine—Paraesthesia—Bleomycin—melanoma	0.000435	0.00269	CcSEcCtD
Mefloquine—Convulsion—Temozolomide—melanoma	0.000434	0.00268	CcSEcCtD
Mefloquine—Hypertension—Temozolomide—melanoma	0.000432	0.00267	CcSEcCtD
Mefloquine—Dyspnoea—Bleomycin—melanoma	0.000432	0.00267	CcSEcCtD
Mefloquine—Pneumonia—Docetaxel—melanoma	0.000428	0.00265	CcSEcCtD
Mefloquine—Confusional state—Carmustine—melanoma	0.000426	0.00264	CcSEcCtD
Mefloquine—Arthralgia—Temozolomide—melanoma	0.000426	0.00264	CcSEcCtD
Mefloquine—Myalgia—Temozolomide—melanoma	0.000426	0.00264	CcSEcCtD
Mefloquine—Anxiety—Temozolomide—melanoma	0.000425	0.00263	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000423	0.00262	CcSEcCtD
Mefloquine—Oedema—Carmustine—melanoma	0.000423	0.00261	CcSEcCtD
Mefloquine—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000422	0.00261	CcSEcCtD
Mefloquine—Discomfort—Temozolomide—melanoma	0.000421	0.0026	CcSEcCtD
Mefloquine—Decreased appetite—Bleomycin—melanoma	0.000421	0.0026	CcSEcCtD
Mefloquine—Renal failure—Docetaxel—melanoma	0.000419	0.00259	CcSEcCtD
Mefloquine—Neuropathy peripheral—Docetaxel—melanoma	0.000417	0.00258	CcSEcCtD
Mefloquine—Thrombocytopenia—Carmustine—melanoma	0.000414	0.00256	CcSEcCtD
Mefloquine—Tachycardia—Carmustine—melanoma	0.000412	0.00255	CcSEcCtD
Mefloquine—Confusional state—Temozolomide—melanoma	0.000412	0.00255	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000411	0.00255	CcSEcCtD
Mefloquine—Oedema—Temozolomide—melanoma	0.000408	0.00253	CcSEcCtD
Mefloquine—Anaphylactic shock—Temozolomide—melanoma	0.000408	0.00253	CcSEcCtD
Mefloquine—Hepatobiliary disease—Docetaxel—melanoma	0.000403	0.00249	CcSEcCtD
Mefloquine—Nervous system disorder—Temozolomide—melanoma	0.000401	0.00248	CcSEcCtD
Mefloquine—Thrombocytopenia—Temozolomide—melanoma	0.0004	0.00247	CcSEcCtD
Mefloquine—Feeling abnormal—Bleomycin—melanoma	0.000399	0.00247	CcSEcCtD
Mefloquine—Agranulocytosis—Docetaxel—melanoma	0.000397	0.00246	CcSEcCtD
Mefloquine—Skin disorder—Temozolomide—melanoma	0.000397	0.00245	CcSEcCtD
Mefloquine—Hypotension—Carmustine—melanoma	0.000395	0.00244	CcSEcCtD
Mefloquine—Hyperhidrosis—Temozolomide—melanoma	0.000395	0.00244	CcSEcCtD
Mefloquine—Decreased appetite—Dactinomycin—melanoma	0.000393	0.00243	CcSEcCtD
Mefloquine—Fatigue—Dactinomycin—melanoma	0.000389	0.00241	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Carmustine—melanoma	0.000385	0.00238	CcSEcCtD
Mefloquine—Urticaria—Bleomycin—melanoma	0.000385	0.00238	CcSEcCtD
Mefloquine—Body temperature increased—Bleomycin—melanoma	0.000383	0.00237	CcSEcCtD
Mefloquine—BCHE—lymph node—melanoma	0.000382	0.00213	CbGeAlD
Mefloquine—Insomnia—Carmustine—melanoma	0.000382	0.00236	CcSEcCtD
Mefloquine—Paraesthesia—Carmustine—melanoma	0.000379	0.00235	CcSEcCtD
Mefloquine—Dyspnoea—Carmustine—melanoma	0.000377	0.00233	CcSEcCtD
Mefloquine—Somnolence—Carmustine—melanoma	0.000376	0.00232	CcSEcCtD
Mefloquine—Connective tissue disorder—Docetaxel—melanoma	0.000376	0.00232	CcSEcCtD
Mefloquine—Feeling abnormal—Dactinomycin—melanoma	0.000372	0.0023	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000372	0.0023	CcSEcCtD
Mefloquine—Insomnia—Temozolomide—melanoma	0.000369	0.00229	CcSEcCtD
Mefloquine—Gastrointestinal pain—Dactinomycin—melanoma	0.000369	0.00228	CcSEcCtD
Mefloquine—Visual impairment—Docetaxel—melanoma	0.000368	0.00228	CcSEcCtD
Mefloquine—Decreased appetite—Carmustine—melanoma	0.000367	0.00227	CcSEcCtD
Mefloquine—Paraesthesia—Temozolomide—melanoma	0.000367	0.00227	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Carmustine—melanoma	0.000365	0.00226	CcSEcCtD
Mefloquine—Dyspnoea—Temozolomide—melanoma	0.000364	0.00225	CcSEcCtD
Mefloquine—ABCB1—mammalian vulva—melanoma	0.000364	0.00203	CbGeAlD
Mefloquine—Somnolence—Temozolomide—melanoma	0.000363	0.00225	CcSEcCtD
Mefloquine—CYP2D6—head—melanoma	0.000362	0.00202	CbGeAlD
Mefloquine—Erythema multiforme—Docetaxel—melanoma	0.000361	0.00224	CcSEcCtD
Mefloquine—Dyspepsia—Temozolomide—melanoma	0.00036	0.00222	CcSEcCtD
Mefloquine—Eye disorder—Docetaxel—melanoma	0.000357	0.00221	CcSEcCtD
Mefloquine—Abdominal pain—Dactinomycin—melanoma	0.000357	0.00221	CcSEcCtD
Mefloquine—Body temperature increased—Dactinomycin—melanoma	0.000357	0.00221	CcSEcCtD
Mefloquine—Hypersensitivity—Bleomycin—melanoma	0.000357	0.00221	CcSEcCtD
Mefloquine—Decreased appetite—Temozolomide—melanoma	0.000355	0.0022	CcSEcCtD
Mefloquine—Flushing—Docetaxel—melanoma	0.000355	0.0022	CcSEcCtD
Mefloquine—Cardiac disorder—Docetaxel—melanoma	0.000355	0.0022	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Temozolomide—melanoma	0.000353	0.00218	CcSEcCtD
Mefloquine—Fatigue—Temozolomide—melanoma	0.000352	0.00218	CcSEcCtD
Mefloquine—Feeling abnormal—Carmustine—melanoma	0.000348	0.00215	CcSEcCtD
Mefloquine—Asthenia—Bleomycin—melanoma	0.000347	0.00215	CcSEcCtD
Mefloquine—Angiopathy—Docetaxel—melanoma	0.000347	0.00215	CcSEcCtD
Mefloquine—Gastrointestinal pain—Carmustine—melanoma	0.000346	0.00214	CcSEcCtD
Mefloquine—Mediastinal disorder—Docetaxel—melanoma	0.000345	0.00213	CcSEcCtD
Mefloquine—Chills—Docetaxel—melanoma	0.000343	0.00212	CcSEcCtD
Mefloquine—Pruritus—Bleomycin—melanoma	0.000343	0.00212	CcSEcCtD
Mefloquine—Alopecia—Docetaxel—melanoma	0.000338	0.00209	CcSEcCtD
Mefloquine—Feeling abnormal—Temozolomide—melanoma	0.000337	0.00208	CcSEcCtD
Mefloquine—Mental disorder—Docetaxel—melanoma	0.000335	0.00207	CcSEcCtD
Mefloquine—Abdominal pain—Carmustine—melanoma	0.000334	0.00207	CcSEcCtD
Mefloquine—Body temperature increased—Carmustine—melanoma	0.000334	0.00207	CcSEcCtD
Mefloquine—Gastrointestinal pain—Temozolomide—melanoma	0.000334	0.00207	CcSEcCtD
Mefloquine—Malnutrition—Docetaxel—melanoma	0.000333	0.00206	CcSEcCtD
Mefloquine—Erythema—Docetaxel—melanoma	0.000333	0.00206	CcSEcCtD
Mefloquine—Hypersensitivity—Dactinomycin—melanoma	0.000333	0.00206	CcSEcCtD
Mefloquine—Urticaria—Temozolomide—melanoma	0.000324	0.00201	CcSEcCtD
Mefloquine—Asthenia—Dactinomycin—melanoma	0.000324	0.002	CcSEcCtD
Mefloquine—Body temperature increased—Temozolomide—melanoma	0.000323	0.002	CcSEcCtD
Mefloquine—Abdominal pain—Temozolomide—melanoma	0.000323	0.002	CcSEcCtD
Mefloquine—Muscle spasms—Docetaxel—melanoma	0.00032	0.00198	CcSEcCtD
Mefloquine—Hypersensitivity—Carmustine—melanoma	0.000311	0.00193	CcSEcCtD
Mefloquine—Diarrhoea—Dactinomycin—melanoma	0.000309	0.00191	CcSEcCtD
Mefloquine—Vomiting—Bleomycin—melanoma	0.000308	0.0019	CcSEcCtD
Mefloquine—Rash—Bleomycin—melanoma	0.000305	0.00189	CcSEcCtD
Mefloquine—Dermatitis—Bleomycin—melanoma	0.000305	0.00189	CcSEcCtD
Mefloquine—Asthenia—Carmustine—melanoma	0.000303	0.00188	CcSEcCtD
Mefloquine—Hypersensitivity—Temozolomide—melanoma	0.000301	0.00186	CcSEcCtD
Mefloquine—Syncope—Docetaxel—melanoma	0.000298	0.00185	CcSEcCtD
Mefloquine—Leukopenia—Docetaxel—melanoma	0.000298	0.00184	CcSEcCtD
Mefloquine—Palpitations—Docetaxel—melanoma	0.000294	0.00182	CcSEcCtD
Mefloquine—Asthenia—Temozolomide—melanoma	0.000293	0.00181	CcSEcCtD
Mefloquine—Loss of consciousness—Docetaxel—melanoma	0.000292	0.00181	CcSEcCtD
Mefloquine—Diarrhoea—Carmustine—melanoma	0.000289	0.00179	CcSEcCtD
Mefloquine—Pruritus—Temozolomide—melanoma	0.000289	0.00179	CcSEcCtD
Mefloquine—Convulsion—Docetaxel—melanoma	0.000288	0.00178	CcSEcCtD
Mefloquine—Nausea—Bleomycin—melanoma	0.000288	0.00178	CcSEcCtD
Mefloquine—Hypertension—Docetaxel—melanoma	0.000287	0.00178	CcSEcCtD
Mefloquine—Vomiting—Dactinomycin—melanoma	0.000287	0.00178	CcSEcCtD
Mefloquine—Rash—Dactinomycin—melanoma	0.000285	0.00176	CcSEcCtD
Mefloquine—Arthralgia—Docetaxel—melanoma	0.000283	0.00175	CcSEcCtD
Mefloquine—Chest pain—Docetaxel—melanoma	0.000283	0.00175	CcSEcCtD
Mefloquine—Myalgia—Docetaxel—melanoma	0.000283	0.00175	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000281	0.00174	CcSEcCtD
Mefloquine—Dizziness—Carmustine—melanoma	0.000279	0.00173	CcSEcCtD
Mefloquine—Diarrhoea—Temozolomide—melanoma	0.000279	0.00173	CcSEcCtD
Mefloquine—Confusional state—Docetaxel—melanoma	0.000274	0.00169	CcSEcCtD
Mefloquine—Oedema—Docetaxel—melanoma	0.000272	0.00168	CcSEcCtD
Mefloquine—Anaphylactic shock—Docetaxel—melanoma	0.000272	0.00168	CcSEcCtD
Mefloquine—Dizziness—Temozolomide—melanoma	0.00027	0.00167	CcSEcCtD
Mefloquine—Vomiting—Carmustine—melanoma	0.000269	0.00166	CcSEcCtD
Mefloquine—Nausea—Dactinomycin—melanoma	0.000268	0.00166	CcSEcCtD
Mefloquine—Shock—Docetaxel—melanoma	0.000267	0.00165	CcSEcCtD
Mefloquine—Rash—Carmustine—melanoma	0.000266	0.00165	CcSEcCtD
Mefloquine—Nervous system disorder—Docetaxel—melanoma	0.000266	0.00165	CcSEcCtD
Mefloquine—Dermatitis—Carmustine—melanoma	0.000266	0.00165	CcSEcCtD
Mefloquine—Thrombocytopenia—Docetaxel—melanoma	0.000266	0.00165	CcSEcCtD
Mefloquine—Tachycardia—Docetaxel—melanoma	0.000265	0.00164	CcSEcCtD
Mefloquine—Headache—Carmustine—melanoma	0.000265	0.00164	CcSEcCtD
Mefloquine—Skin disorder—Docetaxel—melanoma	0.000264	0.00163	CcSEcCtD
Mefloquine—ABCB1—head—melanoma	0.00026	0.00145	CbGeAlD
Mefloquine—Vomiting—Temozolomide—melanoma	0.00026	0.00161	CcSEcCtD
Mefloquine—Rash—Temozolomide—melanoma	0.000258	0.00159	CcSEcCtD
Mefloquine—Dermatitis—Temozolomide—melanoma	0.000257	0.00159	CcSEcCtD
Mefloquine—Headache—Temozolomide—melanoma	0.000256	0.00158	CcSEcCtD
Mefloquine—Hypotension—Docetaxel—melanoma	0.000254	0.00157	CcSEcCtD
Mefloquine—Nausea—Carmustine—melanoma	0.000251	0.00155	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000247	0.00153	CcSEcCtD
Mefloquine—Insomnia—Docetaxel—melanoma	0.000246	0.00152	CcSEcCtD
Mefloquine—Paraesthesia—Docetaxel—melanoma	0.000244	0.00151	CcSEcCtD
Mefloquine—Nausea—Temozolomide—melanoma	0.000243	0.0015	CcSEcCtD
Mefloquine—Dyspnoea—Docetaxel—melanoma	0.000242	0.0015	CcSEcCtD
Mefloquine—Somnolence—Docetaxel—melanoma	0.000241	0.00149	CcSEcCtD
Mefloquine—Dyspepsia—Docetaxel—melanoma	0.000239	0.00148	CcSEcCtD
Mefloquine—Decreased appetite—Docetaxel—melanoma	0.000236	0.00146	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Docetaxel—melanoma	0.000234	0.00145	CcSEcCtD
Mefloquine—Fatigue—Docetaxel—melanoma	0.000234	0.00145	CcSEcCtD
Mefloquine—Feeling abnormal—Docetaxel—melanoma	0.000224	0.00138	CcSEcCtD
Mefloquine—Gastrointestinal pain—Docetaxel—melanoma	0.000222	0.00137	CcSEcCtD
Mefloquine—Abdominal pain—Docetaxel—melanoma	0.000215	0.00133	CcSEcCtD
Mefloquine—Body temperature increased—Docetaxel—melanoma	0.000215	0.00133	CcSEcCtD
Mefloquine—Hypersensitivity—Docetaxel—melanoma	0.0002	0.00124	CcSEcCtD
Mefloquine—Asthenia—Docetaxel—melanoma	0.000195	0.00121	CcSEcCtD
Mefloquine—Pruritus—Docetaxel—melanoma	0.000192	0.00119	CcSEcCtD
Mefloquine—Diarrhoea—Docetaxel—melanoma	0.000186	0.00115	CcSEcCtD
Mefloquine—ABCB1—lymph node—melanoma	0.000182	0.00102	CbGeAlD
Mefloquine—Dizziness—Docetaxel—melanoma	0.00018	0.00111	CcSEcCtD
Mefloquine—Vomiting—Docetaxel—melanoma	0.000173	0.00107	CcSEcCtD
Mefloquine—Rash—Docetaxel—melanoma	0.000171	0.00106	CcSEcCtD
Mefloquine—Dermatitis—Docetaxel—melanoma	0.000171	0.00106	CcSEcCtD
Mefloquine—Headache—Docetaxel—melanoma	0.00017	0.00105	CcSEcCtD
Mefloquine—Nausea—Docetaxel—melanoma	0.000161	0.000998	CcSEcCtD
Mefloquine—ABCB1—Metabolism—CSPG4—melanoma	2.08e-05	0.000121	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—BSG—melanoma	2.08e-05	0.000121	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CSF2—melanoma	2.08e-05	0.000121	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—FGF1—melanoma	2.08e-05	0.000121	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—HPSE—melanoma	2.07e-05	0.000121	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—ABCB1—melanoma	2.07e-05	0.00012	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NOTCH1—melanoma	2.07e-05	0.00012	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—IL2—melanoma	2.05e-05	0.000119	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.04e-05	0.000119	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—E2F1—melanoma	2.03e-05	0.000118	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CUBN—melanoma	2.03e-05	0.000118	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CD80—melanoma	2.02e-05	0.000118	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—PIK3CB—melanoma	2.02e-05	0.000118	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—APC—melanoma	2.02e-05	0.000118	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PIK3CG—melanoma	2.02e-05	0.000118	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—KIT—melanoma	2.02e-05	0.000118	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—NRAS—melanoma	2.02e-05	0.000118	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GPAM—melanoma	2.01e-05	0.000117	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PDGFRA—melanoma	2.01e-05	0.000117	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—EGF—melanoma	2e-05	0.000116	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—ITGB3—melanoma	1.99e-05	0.000116	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PRKCA—melanoma	1.99e-05	0.000116	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.98e-05	0.000115	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	1.97e-05	0.000115	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—CTNNB1—melanoma	1.96e-05	0.000114	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—BSG—melanoma	1.96e-05	0.000114	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—SDHD—melanoma	1.96e-05	0.000114	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CSPG4—melanoma	1.96e-05	0.000114	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—SPP1—melanoma	1.95e-05	0.000114	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MAP2K2—melanoma	1.95e-05	0.000113	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CXCL8—melanoma	1.94e-05	0.000113	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—MAPK3—melanoma	1.94e-05	0.000113	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	1.92e-05	0.000112	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PRKCA—melanoma	1.9e-05	0.000111	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—ABCB1—melanoma	1.9e-05	0.000111	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—CXCL8—melanoma	1.9e-05	0.000111	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—BRAF—melanoma	1.9e-05	0.000111	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GPAM—melanoma	1.9e-05	0.000111	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—ERCC2—melanoma	1.89e-05	0.00011	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.88e-05	0.000109	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.88e-05	0.000109	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—IL2—melanoma	1.86e-05	0.000108	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TERT—melanoma	1.85e-05	0.000108	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IGF1—melanoma	1.85e-05	0.000108	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—RAC1—melanoma	1.85e-05	0.000108	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ABCB1—melanoma	1.84e-05	0.000107	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—MAPK1—melanoma	1.84e-05	0.000107	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—EGFR—melanoma	1.84e-05	0.000107	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MAP2K1—melanoma	1.79e-05	0.000104	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.79e-05	0.000104	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PIK3CD—melanoma	1.78e-05	0.000104	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.77e-05	0.000103	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HIF1A—melanoma	1.77e-05	0.000103	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—PIK3CA—melanoma	1.76e-05	0.000103	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—CTNNB1—melanoma	1.75e-05	0.000102	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PRKCA—melanoma	1.75e-05	0.000102	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—KRAS—melanoma	1.74e-05	0.000101	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—ERCC2—melanoma	1.73e-05	0.000101	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PLA2G6—melanoma	1.71e-05	9.98e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—FGF2—melanoma	1.7e-05	9.91e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PRKCA—melanoma	1.7e-05	9.89e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—KDR—melanoma	1.69e-05	9.87e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PLCB4—melanoma	1.69e-05	9.86e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ERCC2—melanoma	1.68e-05	9.81e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—FN1—melanoma	1.63e-05	9.5e-05	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.63e-05	9.5e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PLA2G6—melanoma	1.61e-05	9.41e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—PIK3CA—melanoma	1.6e-05	9.31e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NOTCH1—melanoma	1.6e-05	9.3e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MDM2—melanoma	1.59e-05	9.27e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SLC6A11—melanoma	1.59e-05	9.27e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PIP4K2A—melanoma	1.59e-05	9.27e-05	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.58e-05	9.19e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—ERBB2—melanoma	1.57e-05	9.14e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.56e-05	9.11e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CD80—melanoma	1.56e-05	9.11e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PIK3CG—melanoma	1.56e-05	9.09e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—APC—melanoma	1.56e-05	9.09e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—KIT—melanoma	1.56e-05	9.09e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—NRAS—melanoma	1.56e-05	9.09e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PIK3CB—melanoma	1.55e-05	9.02e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—MTAP—melanoma	1.55e-05	9.01e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—EGF—melanoma	1.54e-05	8.99e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—VCAN—melanoma	1.54e-05	8.97e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—MAPK3—melanoma	1.49e-05	8.71e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PIK3CG—melanoma	1.49e-05	8.69e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CXCL8—melanoma	1.49e-05	8.67e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—HRAS—melanoma	1.48e-05	8.62e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—BRAF—melanoma	1.47e-05	8.55e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CDKN1B—melanoma	1.45e-05	8.47e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—VCAN—melanoma	1.45e-05	8.45e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PPARG—melanoma	1.44e-05	8.38e-05	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—AKT1—melanoma	1.44e-05	8.38e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.44e-05	8.37e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IGF1—melanoma	1.43e-05	8.32e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CASP3—melanoma	1.42e-05	8.3e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IL2—melanoma	1.42e-05	8.29e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—MAPK1—melanoma	1.42e-05	8.29e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—EGFR—melanoma	1.42e-05	8.28e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—IL6—melanoma	1.41e-05	8.25e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.39e-05	8.13e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CCND1—melanoma	1.39e-05	8.08e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MAP2K1—melanoma	1.38e-05	8.05e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—LUM—melanoma	1.38e-05	8.03e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PHGDH—melanoma	1.38e-05	8.03e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CTNNB1—melanoma	1.37e-05	8e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PIK3CD—melanoma	1.37e-05	7.99e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PIK3CG—melanoma	1.37e-05	7.98e-05	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—PIK3CA—melanoma	1.36e-05	7.92e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—HPSE—melanoma	1.35e-05	7.88e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MMP9—melanoma	1.35e-05	7.84e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—KRAS—melanoma	1.34e-05	7.83e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CDKN1A—melanoma	1.34e-05	7.82e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PTEN—melanoma	1.34e-05	7.8e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NFKB1—melanoma	1.33e-05	7.76e-05	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.33e-05	7.76e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PIK3CG—melanoma	1.33e-05	7.75e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CUBN—melanoma	1.33e-05	7.73e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PPARG—melanoma	1.32e-05	7.7e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—FGF2—melanoma	1.31e-05	7.65e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PIK3CD—melanoma	1.31e-05	7.63e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—AKT1—melanoma	1.31e-05	7.61e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CYP17A1—melanoma	1.3e-05	7.57e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—ALB—melanoma	1.29e-05	7.54e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PPARG—melanoma	1.28e-05	7.48e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—BSG—melanoma	1.28e-05	7.47e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SDHD—melanoma	1.28e-05	7.47e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CSPG4—melanoma	1.28e-05	7.47e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GPAM—melanoma	1.24e-05	7.23e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—PIK3CA—melanoma	1.23e-05	7.19e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MDM2—melanoma	1.23e-05	7.16e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GNA11—melanoma	1.23e-05	7.15e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CYP17A1—melanoma	1.22e-05	7.13e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—ERBB2—melanoma	1.21e-05	7.06e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—VEGFA—melanoma	1.21e-05	7.04e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PIK3CD—melanoma	1.2e-05	7.02e-05	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.2e-05	7e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—FASN—melanoma	1.2e-05	6.99e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—STAT3—melanoma	1.2e-05	6.97e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PIK3CB—melanoma	1.2e-05	6.97e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NRAS—melanoma	1.19e-05	6.96e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—ALB—melanoma	1.19e-05	6.93e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—SLC5A5—melanoma	1.18e-05	6.88e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PIK3CD—melanoma	1.17e-05	6.81e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GNA11—melanoma	1.16e-05	6.73e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ALB—melanoma	1.15e-05	6.72e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CXCL8—melanoma	1.15e-05	6.7e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MAPK3—melanoma	1.14e-05	6.66e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PIK3CB—melanoma	1.14e-05	6.65e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—HRAS—melanoma	1.14e-05	6.65e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GNAQ—melanoma	1.14e-05	6.64e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CD44—melanoma	1.14e-05	6.64e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PTGS2—melanoma	1.13e-05	6.59e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—FASN—melanoma	1.13e-05	6.59e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CDKN1B—melanoma	1.12e-05	6.54e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—SLC5A5—melanoma	1.11e-05	6.48e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MYC—melanoma	1.11e-05	6.48e-05	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—AKT1—melanoma	1.11e-05	6.47e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CASP3—melanoma	1.1e-05	6.41e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IL2—melanoma	1.1e-05	6.4e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CYP1B1—melanoma	1.09e-05	6.37e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—IL6—melanoma	1.09e-05	6.37e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MAPK1—melanoma	1.09e-05	6.34e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—EGFR—melanoma	1.09e-05	6.34e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GNAQ—melanoma	1.07e-05	6.26e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CD44—melanoma	1.07e-05	6.26e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCND1—melanoma	1.07e-05	6.24e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CTNNB1—melanoma	1.06e-05	6.18e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PLA2G6—melanoma	1.06e-05	6.15e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PIK3CB—melanoma	1.05e-05	6.12e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PTGS2—melanoma	1.04e-05	6.06e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MMP9—melanoma	1.04e-05	6.06e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CDKN1A—melanoma	1.04e-05	6.03e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PTEN—melanoma	1.03e-05	6.02e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CYP1B1—melanoma	1.03e-05	6e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NFKB1—melanoma	1.03e-05	5.99e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—KRAS—melanoma	1.03e-05	5.99e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PIK3CB—melanoma	1.02e-05	5.94e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PTGS2—melanoma	1.01e-05	5.88e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—AKT1—melanoma	1.01e-05	5.87e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PTEN—melanoma	9.87e-06	5.75e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—VCAN—melanoma	9.48e-06	5.52e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PIK3CA—melanoma	9.44e-06	5.5e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—VEGFA—melanoma	9.33e-06	5.44e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—STAT3—melanoma	9.24e-06	5.38e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NRAS—melanoma	9.22e-06	5.37e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TP53—melanoma	9.13e-06	5.32e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PTEN—melanoma	9.07e-06	5.28e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MAPK3—melanoma	8.83e-06	5.14e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PTEN—melanoma	8.8e-06	5.13e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HRAS—melanoma	8.73e-06	5.09e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MYC—melanoma	8.58e-06	5e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ABCB1—melanoma	8.48e-06	4.94e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MAPK1—melanoma	8.4e-06	4.89e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—EGFR—melanoma	8.4e-06	4.89e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IL6—melanoma	8.36e-06	4.87e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PRKCA—melanoma	8.28e-06	4.83e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ERCC2—melanoma	8.21e-06	4.79e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CYP17A1—melanoma	8e-06	4.66e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—KRAS—melanoma	7.93e-06	4.62e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PRKCA—melanoma	7.8e-06	4.55e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ERCC2—melanoma	7.74e-06	4.51e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—AKT1—melanoma	7.71e-06	4.49e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GNA11—melanoma	7.55e-06	4.4e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—FASN—melanoma	7.39e-06	4.31e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PIK3CA—melanoma	7.29e-06	4.25e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SLC5A5—melanoma	7.27e-06	4.24e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TP53—melanoma	7.05e-06	4.11e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GNAQ—melanoma	7.02e-06	4.09e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CD44—melanoma	7.02e-06	4.09e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PIK3CA—melanoma	6.96e-06	4.06e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HRAS—melanoma	6.74e-06	3.93e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CYP1B1—melanoma	6.73e-06	3.92e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PIK3CG—melanoma	6.49e-06	3.78e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IL6—melanoma	6.45e-06	3.76e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PIK3CA—melanoma	6.4e-06	3.73e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PPARG—melanoma	6.26e-06	3.65e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PIK3CA—melanoma	6.21e-06	3.62e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PIK3CG—melanoma	6.11e-06	3.56e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—AKT1—melanoma	5.95e-06	3.47e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PPARG—melanoma	5.9e-06	3.44e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PIK3CD—melanoma	5.7e-06	3.32e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—AKT1—melanoma	5.69e-06	3.31e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ALB—melanoma	5.63e-06	3.28e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ABCB1—melanoma	5.54e-06	3.23e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PIK3CD—melanoma	5.37e-06	3.13e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ALB—melanoma	5.3e-06	3.09e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—AKT1—melanoma	5.23e-06	3.05e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PRKCA—melanoma	5.1e-06	2.97e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—AKT1—melanoma	5.07e-06	2.96e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ERCC2—melanoma	5.06e-06	2.95e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PIK3CB—melanoma	4.97e-06	2.9e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PTGS2—melanoma	4.92e-06	2.87e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PIK3CB—melanoma	4.68e-06	2.73e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PTGS2—melanoma	4.64e-06	2.7e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PTEN—melanoma	4.29e-06	2.5e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PTEN—melanoma	4.05e-06	2.36e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PIK3CG—melanoma	4e-06	2.33e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PPARG—melanoma	3.86e-06	2.25e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PIK3CD—melanoma	3.51e-06	2.05e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ALB—melanoma	3.47e-06	2.02e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PIK3CB—melanoma	3.06e-06	1.78e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PTGS2—melanoma	3.03e-06	1.77e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PIK3CA—melanoma	3.03e-06	1.77e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PIK3CA—melanoma	2.86e-06	1.66e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PTEN—melanoma	2.65e-06	1.54e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—AKT1—melanoma	2.48e-06	1.44e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—AKT1—melanoma	2.33e-06	1.36e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PIK3CA—melanoma	1.87e-06	1.09e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—AKT1—melanoma	1.52e-06	8.89e-06	CbGpPWpGaD
